Can CD3 +/HLA-DR + activated T cells predict the prognosis of non-Hodgkin's lymphoma patients?

Immunology Letters

Volumn 97, Issue 1, 2005, Pages 155-157

  Váróczy, László ^a   Gergely, Lajos ^a   Miltényi, Zsófia ^a   Aleksza, Magdolna ^a   Illés, Árpád ^a  

^a Med Hlth Sci Ctr Univ D   (Hungary)

Author keywords

Activated T cell; CD3 + HLA DR +; Flow cytometry; Non Hodgkin's lymphoma

Indexed keywords

BLEOMYCIN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; HLA DR ANTIGEN; MEPREDNISONE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; MALE; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; FEMALE; HLA-DR ANTIGENS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTES;

EID: 11144315982     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.10.005     Document Type: Article

References (7)

1. J. Trowsdale Molecular genetics of HLA class I and class II regions HLA and MHC genes, molecules and function 1996 BIOS Scientific Publishers p. 152-165
2. A. Caruso, S. Licenziati, M. Corulli, A.D. Canaris, M.A. De Francesco, S. Fiorentini, L. Peroni, F. Fallacara, F. Dima, A. Balsari, and A. Turano Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation Cytometry 27 1997 71 76
3. J.M. Vose, Chiu BCH, B.D. Cheson, J. Dancey, and J. Wright Update on epidemiology and therapeutics for non-Hodgkin's lymphoma Hematology 2002 241 262
4. + peripheral T cells of patients with atopic dermatitis Br. J. Dermatol. 147 2002 1135 1141
5. J.J.F. Muris, C.J.L.M. Meijer, S.A.G.M. Cillessen, W. Vos, J.A. Kummer, B.A. Bladergroen, M.J.J.T. Bogman, M.A. MacKenzie, N.M. Jiwa, L.H. Siegenbeek van Heukelom, G.J. Ossenkoppele, and J.J. Oudejans Prognostic significance of activated cytotoxic T lymphocytes in primary nodal diffuse large B-cell lymphomas Leukemia 18 2004 589 596
6. + T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome J. Clin. Oncol. 19 2001 720 726
7. H. Bosshart T-helper cell activation in B-cell lymphomas J. Clin. Oncol. 20 2002 2904 2913